• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
    • Emerging Biopharma
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
    • Emerging Biopharma
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

Biotech

Biotech

FDA slaps hold on 4DMT's phase 1/2 gene therapy trial

4D Molecular Therapeutics is on shaky ground as its Fabry disease gene therapy program has been hit with an FDA clinical hold.  
Gabrielle Masson Feb 3, 2023 1:28pm

Sanofi CEO plots path ‘back to the magic’ in oncology

Feb 3, 2023 11:12am

Fierce Biotech Layoff Tracker 2023: Eisai, Vyant and more

Feb 3, 2023 11:00am

New federal biotech commission taps 12 members—Chutes & Ladders

Feb 3, 2023 10:20am

Drug discovery biotech Vyant preps to wind down operations

Feb 3, 2023 10:14am

After 18-month hold, MaaT sees end to impasse with FDA

Feb 3, 2023 9:55am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy